Peripheral IR was found in patients with colorectal cancer [15], non-small cell lung cancer (NSCLC) [16], gastrointestinal cancer [17], and mixed malignancies [18] by measuring insulin sensitivity using the gold-standard hyperinsulinemic-euglycemic clamp technique. The gene discussed is INS; the disease is non-small cell lung carcinoma.